About

About

Clear Almanac 34 is an independent resource offering clear, evidence-first information about ibogaine, noribogaine, and laboratory testing methods. Our aim is pragmatic clarity: explain what is known, where uncertainty remains, and how to find credible source material.

Lantern Phase — independent information
Close-up detail view related to ibogaine testing showing a clinical sample vial and annotated notes

Our editorial approach

We assemble material from peer-reviewed literature, laboratory standards, and official guidance to present balanced summaries. Our editorial process emphasizes transparency: sources are cited inline where they substantiate specific claims, and we favour primary sources over summaries.

To support how we vet methods we reference established repositories such as the U.S. National Library of Medicine and general standards observed by clinical toxicology labs; for example, authoritative context about laboratory practice can be found on sites like the Clinical Chemistry overview on Wikipedia.

What we cover

Content is structured for readers seeking clarity about testing methods, interpretation limits, and differences in laboratory practice. We organize material into concise guides, specimen comparison pages, and explanatory articles that highlight uncertainty and methodological caveats.

Editorial sections include featured insights, topic clusters, and in-depth explanations; search and navigation are organized so a reader can move from a high-level overview into detailed technical notes without losing context. If you'd like a broader entry point to our site, our front page provides a curated starting path and links into the deeper sections like services and the detection guide — for example, one reader found the route via the site landing summary.

Principle: clarity over persuasion — we present tradeoffs, uncertainty, and the quality of evidence so readers can make informed decisions.

How information is sourced

We prioritize primary sources: peer-reviewed journals, method manuals from accredited laboratories, regulatory guidance, and recognized standards bodies. Where appropriate we link to institutional pages such as the U.S. Food and Drug Administration for testing-device approvals or university-hosted materials that explain laboratory validation practices; for instance, the FDA's pages on laboratory devices provide context about regulation and device claims at FDA Medical Devices.

We maintain editorial notes describing when a claim is based on limited evidence or expert consensus rather than definitive study results. Our goal is to make the provenance of each point easy to follow.

Editorial principles

  • Independence: no clinical services, no promotions of specific providers.
  • Plain language: technical accuracy presented accessibly.
  • Method clarity: stepwise explanation of assays, panels, and limitations.
  • Safety-first: content avoids operational advice that could be misused.
  • Honest uncertainty: we flag weak evidence and open questions.

Who this is for

This resource is intended for clinicians, researchers, laboratory staff, people preparing for workplace or legal testing, and curious readers seeking method-focused explanations. We do not provide individualized medical or legal advice.

If you are seeking clinical services, treatment referrals, or personalized interpretation, please consult licensed professionals. Our Services page describes how non-clinical support resources are presented and linked from the site.

Transparency and external context

When we reference laboratory practice we often point to recognized academic resources and aggregation pages. For methodology context, readers may consult university-hosted materials; for instance, educational content from large academic institutions provides background on laboratory validation and interpretation, such as material hosted by the University of California's clinical lab resources at UCSF or general overviews at well-maintained encyclopedic sources like Wikipedia's drug testing article.

We also review publicly visible clinic and provider pages to understand the range of practices readers encounter. Examples include provider sites that describe patient-facing logistics: Canadian provider information, an informational program page, a comparative provider resource, anti-addiction program notes, and practical pages summarizing emerging efforts such as fentanyl-focused informational content. These are cited to show publicly-stated practices, not to endorse any program.

External links to provider pages open in a new tab so readers can review original wording and claims directly.

Independent by design

Clear Almanac 34 is an independent editorial resource. We are not a clinic, medical provider, or a licensed treatment center. Our content is intended for information purposes only and is not medical or legal advice.

If you need clinical evaluation or legal guidance, please consult licensed professionals. Our pages include citations so readers can follow source material to primary documents and institutional guidance.